[Informe de investigación] Se proyecta que el mercado de inmunohistoquímica alcanzará los 3.585,31 millones de dólares en 2028 desde los 2.171,61 millones de dólares de 2021; se estima que registrará una tasa compuesta anual del 7,4 % entre 2021 y 2028.
Perspectivas del mercado y visión del analista:< /u>
La inmunohistoquímica (IHC) es una herramienta que utiliza técnicas basadas en microscopía para observar componentes celulares como proteínas u otras macromoléculas en una muestra de tejido. Es una herramienta de uso habitual en atención sanitaria y patología. La IHC se utiliza ampliamente en aplicaciones de investigación donde se analizan moléculas de interés para estudiar sus funciones en células y tejidos sanos y enfermos a nivel celular, molecular o tisular. Existen numerosos métodos IHC que pueden utilizarse para localizar antígenos. Parámetros como los tipos de muestras y la sensibilidad del ensayo se consideran principalmente en IHC. Se espera que el tamaño del mercado mundial de inmunohistoquímica ihc alcance los 3.585,31 millones de dólares en 2028 desde los 2.1716,1 millones de dólares en 2021. Se estima que el mercado crecerá con una tasa compuesta anual del 7,4% entre 2021 y 2028.
Impulsores y desafíos del crecimiento:
Incidencia creciente de enfermedades crónicas y enfermedades infecciosas
La inmunohistoquímica (IHC) se refiere a una aplicación importante de anticuerpos monoclonales y policlonales para la determinación tisular y la distribución de antígenos de una enfermedad particular. Se utiliza principalmente para detectar varios trastornos infecciosos como el dengue, la hepatitis y el virus de la inmunodeficiencia humana (VIH). Las afecciones médicas crónicas, como la obesidad, el cáncer, la diabetes, las enfermedades cardíacas y los accidentes cerebrovasculares, también se consideran las principales aplicaciones de la inmunohistoquímica que ayudan en el diagnóstico de estas enfermedades.
Según el Programa Conjunto de las Naciones Unidas sobre el VIH/SIDA (ONUSIDA), en 2020 había aproximadamente 37,6 millones de personas en todo el mundo con VIH. De ellas, 35,9 millones eran adultos y 1,7 millones eran niños (<15 años). Se estima que 1,5 millones de personas en todo el mundo contrajeron el VIH en 2020. Según la organización VIH y SIDA (AVERT), en 2018, 1,1 millones de residentes de EE. UU. estaban infectados con el VIH, mientras que APAC registró 5,2 millones de personas infectadas por el VIH. Según los CDC europeos, ~2 millones de personas en Europa se infectaron con el VIH en 2018.
La diabetes prevalece a un ritmo elevado en la población geriátrica de todo el mundo. La prevalencia de diabetes es mayor en personas con sobrepeso y obesidad. Según datos publicados por el Centro para el Control y la Prevención de Enfermedades (CDC) en 2017, ~30,3 millones de personas, que representan el 94% de la población de EE. UU., son diabéticas. Entre ellos, ~23,1 millones de personas son diagnosticadas con diabetes, mientras que ~7,2 millones de personas no se han sometido a un procedimiento de diagnóstico adecuado.
Las tasas de obesidad también han aumentado rápidamente en los países desarrollados. como economías en desarrollo en todo el mundo. Factores como el estilo de vida poco saludable y el sedentarismo se encuentran entre los principales responsables del aumento del número de personas obesas. Según los datos publicados por el Centro Nacional de Estadísticas de Salud (NCHS), se espera que la prevalencia de la obesidad sea de alrededor del 39,8 %, afectando a alrededor de 93,3 millones de adultos estadounidenses entre los años 2015 y 2016. Se observó que la incidencia de la obesidad era significativamente alta. entre los adultos de mediana edad (42,7%) en comparación con los adultos más jóvenes (35,7%). El aumento del número de personas obesas en los Estados Unidos también ha provocado un aumento del gasto en atención sanitaria.
Las enfermedades cardiovasculares (ECV) incluyen enfermedades cerebrovasculares, enfermedades cardíacas reumáticas y enfermedades coronarias. enfermedad y otras condiciones. Es la causa más importante de morbilidad y mortalidad en todo el mundo. Según las Estadísticas Europeas de Enfermedades Cardiovasculares de 2017, cada año las enfermedades cardiovasculares causan 3,9 millones de muertes y más de 1,8 millones de muertes en la Unión Europea (UE). Las enfermedades cardiovasculares representan el 45,0% de todas las muertes en Europa y el 37,0% de las muertes en la UE. Además, según las estadísticas de 2019 de la Asociación Estadounidense del Corazón (AHA), 121,5 millones de adultos en los EE. UU., que representan aproximadamente la mitad de la población adulta de los EE. UU., sufren de enfermedades cardiovasculares.
Además, ha habido un aumento en las tasas de incidencia y mortalidad del cáncer en todo el mundo, lo que convierte al cáncer en la principal causa de muerte. Según la Organización Mundial de la Salud, en 2018, aproximadamente 9,6 millones de muertes en todo el mundo se debieron al cáncer.
Además, el Instituto Nacional del Cáncer predijo que en 2018, aproximadamente 1.735.350 nuevos casos de cáncer De manera similar, en China, según los datos revelados por la OMS, se detectaron ~4,3 millones de nuevos casos de cáncer y se registraron 2,9 millones de muertes por cáncer en 2018. Tal aumento en la incidencia de enfermedades crónicas y Se espera que las enfermedades infecciosas creen una demanda de pruebas de inmunoensayo en todo el mundo.
Perspectivas estratégicas
< /p>Restricciones del mercado
Limitaciones asociadas con la inmunohistoquímica< /u>
La inmunohistoquímica emplea la especificidad de los anticuerpos para detectar moléculas diana entre tejidos o células. Además, la IHC también ha demostrado ser una técnica poderosa en investigación toxicológica. Sin embargo, algunas de las limitaciones asociadas con la especificidad y precisión de la técnica limitan su adopción a un cierto nivel.
La falta de especificidad de los reactivos es un problema más común que es generalmente reconocido. La falta de especificidad puede resultar en un enorme desperdicio en términos de recursos y tiempo. Además, la aplicación de la técnica también está limitada por las limitaciones físicas de los anticuerpos. Además, la inmunohistoquímica puede ser engañosa si el diseño del estudio de tinción no se concibe y controla cuidadosamente.
Aunque este sistema es el método más simple y conveniente para la detección de una determinada expresión de marcador , no se emplea eficazmente en aplicaciones clínicas y de investigación debido a limitaciones como una sensibilidad insuficiente, la necesidad de que cada anticuerpo primario se conjugue individualmente con fluoróforos o enzimas y problemas de tinción. Por lo tanto, las limitaciones asociadas con la técnica IHC pueden obstaculizar el crecimiento del mercado hasta cierto punto.
Segmentación y alcance del informe:
El “Mercado Global de Inmunohistoquímica” está segmentado según la aplicación, el producto, el usuario final y la geografía. El mercado mundial de inmunohistoquímica, basado en productos, se ha segmentado en anticuerpos, equipos, reactivos y kits. El mercado mundial de inmunohistoquímica, basado en la aplicación, se segmenta en diagnóstico y pruebas de drogas. En 2021, es probable que el segmento de diagnóstico tenga la mayor participación del mercado. El mercado global de inmunohistoquímica, basado en el usuario final, se segmentó en hospitales y hospitales. laboratorios de diagnóstico, institutos de investigación y otros. El mercado de inmunohistoquímica, según la geografía, está segmentado en América del Norte (EE. UU., Canadá y México), Europa (Alemania, Francia, Italia, Reino Unido, Rusia y resto de Europa), Asia Pacífico (Australia, China, Japón, India, Corea del Sur y resto de Asia Pacífico), Oriente Medio y Asia. África (Sudáfrica, Arabia Saudita, Emiratos Árabes Unidos y resto de Medio Oriente y África) y Sur y África. Centroamérica (Brasil, Argentina y resto de Centro y Suramérica)
Análisis segmentario:
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Antibodies is the most influencing segment growing in the immunohistochemistry market.
Development opportunities in emerging countries are likely to fuel the market growth in the comping years.
Increasing acceptance of automation in immunohistochemistry is likely to act as trend the market growth in the comping years.
Key players in the market are F. Hoffmann-LA Roche AG, Merck KGaA, PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Abcam Plc, Agilent Technologies, Bio SB, Bio-Rad Laboratories, Cell Signaling Technology, Inc., and Danaher Corporation among others.
Key factors driving the growth of the market are rising incidences of chronic and infectious diseases, increasing geriatric population, and increasing R&D investments by biotechnology & biopharmaceutical companies are among the key factors driving the market.
Immunohistochemistry is a tool used microscopy-based techniques to observe cellular components such as proteins or other macromolecules in a tissue sample. It is routinely used tool in health care and pathology. IHC is widely used in research application where molecules of interest are analyzed to study their roles in both healthy and diseased cells and tissues on the cellular, molecular, or tissue level. There are numerous IHC methods that can be used to localize antigens. Parameters like specimen types and assay sensitivity are majorly considered in IHC.
Asia-Pacific is the lucrative for the immunohistochemistry market.
The List of Companies - Immunohistochemistry Market
- F. Hoffmann-LA Roche AG
- Merck KGaA
- PerkinElmer, Inc.
- Thermo Fisher Scientific, Inc.
- Abcam Plc
- Agilent Technologies
- Bio SB
- Bio-Rad Laboratories
- Cell Signaling Technology, Inc.
- Danaher Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Sep 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Sep 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Sep 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Sep 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)